Joseph Beaulieu - See Remarks, Epizyme, Inc

As of March 21, 2022


What is Joseph Beaulieu's Net Worth?

The current estimated net worth of Epizyme, Inc's See Remarks, Joseph Beaulieu, is estimated to be about $64.87K . Joseph Beaulieu owns about 28,632 units of Epizyme, Inc common stock. In the last 3 years at Epizyme, Inc, Joseph Beaulieu has sold an estimated value of $64.25K worth.

What is Joseph Beaulieu's Past Insider Trading?

Joseph Beaulieu's largest sale order was 996 units , worth over $22.09K on March 5, 2020. In total, Joseph Beaulieu has made about 14 transactions over 3 years of their time at Epizyme, Inc. Joseph Beaulieu usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 222 units , worth over $333 on February 9, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Joseph Beaulieu's' Mailing Address?

  • Mailing address is C/o Epizyme, Inc. 400 Technology Square Cambridge MA 02139 MA

Epizyme, Inc Executive Compensation

Name
Year
Salary
Bonus
Restricted Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert B. Bazemore Jr. 2020 $650,000 - $3,237,620 $4,103,853 $370,500 $96,369 $8,458,342
Robert B. Bazemore Jr. 2019 $592,937 - $1,105,393 $2,060,531 $409,127 $5,630 $4,173,618
Robert B. Bazemore Jr. 2018 $575,667 - - $2,748,939 $320,575 $5,690 $3,650,871
Paolo Tombesi 2020 $460,000 - $250,006 $750,730 $174,800 $48,198 $1,683,734
Paolo Tombesi 2019 $168,901 - $612,848 $1,173,669 $76,076 $146,971 $2,178,465
Matthew E. Ros 2020 $447,982 - $250,006 $750,730 $174,800 $11,271 $1,634,789
Matthew E. Ros 2019 $432,600 - $538,793 $899,137 $199,861 $11,598 $2,081,989
Matthew E. Ros 2018 $420,000 - - $1,099,576 $187,100 $12,214 $1,718,890
Dr. Shefali Agarwal 2020 $478,000 - $274,990 $825,799 $199,804 $7,154 $1,785,747
Dr. Shefali Agarwal 2019 $463,500 - $894,607 $1,255,325 $265,122 $8,652 $2,887,206
Dr. Shefali Agarwal 2018 $199,615 $125,000 - $1,472,846 $200,500 $1,648 $1,999,609
Jeffery L. Kutok, M.D., Ph.D. 2020 $337,500 $85,000 $374,996 $1,124,996 $134,663 $6,813 $2,063,968
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm

What are Epizyme, Inc's Past Insider Trades?

Epizyme, Inc's most recent insider trade came on April 13, 2022 by Jeffery Kutok who sold 2,741 units worth $2.47K . In the last 9 years, insiders at Epizyme, Inc have sold an estimated value of $153.29M and bought an estimated value of $377.73M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are David Mott, Director,  Robert Copeland, President Research and CSO,  and Andrew Singer, EVP & CFO .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1